Linoleic acid attenuates endothelium-derived relaxing factor production by suppressing cAMP-hydrolyzing phosphodiesterase activity

Circ J. 2013;77(11):2823-30. doi: 10.1253/circj.cj-13-0248. Epub 2013 Jul 25.

Abstract

Background: Linoleic acid (LA) promotes monocyte chemotaxis and cell adhesion molecules such as MCP-1 and VCAM-1, which contribute to atherosclerogenesis. These molecules are restrained by endothelium-derived relaxing factors (EDRFs), such as nitric oxide (NO) and prostaglandin I2 (PGI2). Hence, the expressions of MCP-1 and VCAM-1 upregulated by LA may be partly attributable to decreased EDRF production. However, effect of LA on EDRF production remains controversial.

Methods and results: The present study aimed to examine the effects of LA and other free fatty acids on EDRF production and the endothelial Ca(2+) responses that mediate EDRF production, using primary cultured porcine aortic endothelial cells (PAECs). LA at 0.1-5 μmol/L attenuated bradykinin (BK)-induced NO and PGI2 production while suppressing the BK-induced Ca(2+) response dose-dependently. The inhibitory effect of LA on the Ca(2+) response was eliminated by adenylate cyclase inhibitor SQ22536, boosted by cAMP-hydrolyzing phosphodiesterase (PDE) inhibitor, rolipram, and mimicked by plasma membrane permeable 8-bromo-cAMP. Moreover, LA was confirmed to dose-dependently increase intracellular cAMP levels and selectively inhibit cAMP-hydrolyzing PDE activity in vitro. In contrast, none of palmitic, stearic, or oleic acid affected BK-induced EDRF production or Ca(2+) responses, or induced intracellular cAMP accumulation.

Conclusions: LA induced intracellular cAMP accumulation by inhibiting cAMP-hydrolyzing PDE activity, thus resulting in attenuation of Ca(2+) responses and EDRF production in PAECs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors
  • 3',5'-Cyclic-AMP Phosphodiesterases / biosynthesis*
  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Animals
  • Calcium Signaling / drug effects*
  • Calcium Signaling / physiology
  • Cells, Cultured
  • Chemokine CCL2 / biosynthesis
  • Cyclic AMP / metabolism*
  • Dose-Response Relationship, Drug
  • Endothelial Cells / cytology
  • Endothelial Cells / metabolism*
  • Endothelium-Dependent Relaxing Factors / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Epoprostenol / biosynthesis
  • Linoleic Acid / pharmacology*
  • Nitric Oxide / biosynthesis
  • Swine
  • Vascular Cell Adhesion Molecule-1 / biosynthesis

Substances

  • Chemokine CCL2
  • Endothelium-Dependent Relaxing Factors
  • Enzyme Inhibitors
  • Vascular Cell Adhesion Molecule-1
  • 9-(tetrahydro-2-furyl)-adenine
  • Nitric Oxide
  • Linoleic Acid
  • Epoprostenol
  • Cyclic AMP
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Adenine